Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $62,347
76%  
Woo hoo!! And we're now over 76%!! Thank you all very much!! God bless.

Keyword: s309

Brevity: Headers | « Text »
  • One antibody stops all strains of COVID-19 from infecting cells

    09/06/2021 9:37:30 PM PDT · by NoLibZone · 68 replies
    Free thinker ^ | September 4, 2021 | By Kristin Houser
    It neutralized the coronavirus behind the first SARS outbreak, too. newly discovered antibody was able to neutralize not only all strains of COVID-19, but other coronaviruses known to cause respiratory infections in humans — a potential silver bullet for a whole class of deadly, flu-like viruses. Mutant viruses: As viruses spread, they undergo tiny genetic mutations, and when we find a unique version of the virus, we call it a new strain. Occasionally, new strains appear that can spread more easily, evade the immune system, or cause more severe disease. Several worrisome strains of COVID-19 have already appeared during the...
  • SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape

    09/06/2021 10:35:00 PM PDT · by NoLibZone · 6 replies
    nature.com ^ | July 14,2021 | Tyler N. Starr, Nadine Czudnochowski, […]Gyorgy Snell
    ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1,2,3, have activity against diverse sarbecoviruses4,5,6,7, and be highly protective through viral neutralization8,9,10,11 and effector functions12,13. Understanding how these properties relate to each other and vary across epitopes would aid the development of therapeutic antibodies and guide vaccine design. Here we comprehensively characterize escape, breadth and potency across a panel of SARS-CoV-2 antibodies targeting the receptor-binding domain (RBD). Despite a trade-off between in vitro neutralization potency and breadth of sarbecovirus binding, we identify neutralizing antibodies with exceptional sarbecovirus breadth and a corresponding resistance to SARS-CoV-2 escape. One of these antibodies, S2H97, binds with...
  • Scientist at Berkeley Lab Played a Hand in “Inescapable” COVID-19 Antibody Discovery

    09/06/2021 10:27:50 PM PDT · by NoLibZone · 15 replies
    newscenter.lbl.gov ^ | Aug 16 2021 | Aliyah Kovner
    An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix News Center Scientist at Berkeley Lab Played a Hand in “Inescapable” COVID-19 Antibody Discovery An antibody therapy that appears to neutralize all known SARS-CoV-2 strains, and other coronaviruses, was developed with a little help from structural biologist Jay Nix Lifesaving COVID-19 vaccines are allowing us to feel optimistic again, after more than a year of anxiety and tragedy. But vaccines are only one side of the coin – we also need treatments that can prevent...